1. Home
  2. REED vs AIMD Comparison

REED vs AIMD Comparison

Compare REED & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reed's Inc.

REED

Reed's Inc.

N/A

Current Price

$1.01

Market Cap

15.1M

Sector

N/A

ML Signal

N/A

Logo Ainos Inc.

AIMD

Ainos Inc.

HOLD

Current Price

$1.93

Market Cap

13.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REED
AIMD
Founded
1987
1984
Country
United States
United States
Employees
44
41
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.1M
13.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
REED
AIMD
Price
$1.01
$1.93
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
20.1K
43.3K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$18.74
N/A
Revenue Next Year
$18.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.03
$1.26
52 Week High
$5.97
$4.50

Technical Indicators

Market Signals
Indicator
REED
AIMD
Relative Strength Index (RSI) 28.24 49.39
Support Level N/A $1.68
Resistance Level $1.42 $1.98
Average True Range (ATR) 0.15 0.18
MACD 0.02 0.00
Stochastic Oscillator 0.00 29.66

Price Performance

Historical Comparison
REED
AIMD

About REED Reed's Inc.

Reed's Inc is a branded beverage company offering a portfolio of natural, premium, and functional beverages under the Reed's and Virgil's brands. The company's portfolio of handcrafted, all-natural beverages is sold in outlets nationwide, including the natural and specialty food channel, grocery stores, mass merchants, drug stores, convenience stores, club stores, and on-premise locations, including bars and restaurants. The company operates in a single reportable segment, which consists of manufacturing carbonated beverages under Reed's and Virgil's brand names.

About AIMD Ainos Inc.

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

Share on Social Networks: